Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Avricore Health Inc. V.AVCR

Alternate Symbol(s):  AVCRF

Avricore Health Inc. is committed to becoming a health innovator and applying technologies at the forefront of science to core health issues at the community pharmacy level. The Company’s goal is to empower consumers, patients and pharmacists with innovative technology, products, services and information to monitor and optimize health.


TSXV:AVCR - Post by User

Bullboard Posts
Comment by kingposton Jan 05, 2015 1:14am
139 Views
Post# 23285052

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:lscfa

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:lscfa
lscfa wrote: Like I said, an email has just been sent. But don't knock my assumptions by pretending that you know any more than I do. Pompous jerk.


You yourself said, Mylan has 50% margins, we know Canada has much higher generics pricing than America,... with this as a foundation how could you come up with, and still be comfortable with,  10% for NPH???? Absurd... Additionally do you think it would even be worth the risk to do it for 10% margins?? Again do your DD the answer is there for you...

Bullboard Posts